Gerard J. Platenburg

Co-Founder at ProQR Therapeutics NV

Gerard J. Platenburg

Gerard J. Platenburg

Co-Founder at ProQR Therapeutics NV

Overview
Career Highlights

ISA Pharmaceuticals BV
Prosensa Holding NV
ProQR Therapeutics NV

RelSci Relationships

339

Number of Boards

3

Birthday

02/1964

Age

54

Relationships
RelSci Relationships are individuals Gerard J. Platenburg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman at Sofinnova Partners SAS

Relationship likelihood: Strong

Managing Director at Stichting Administratiekantoor Endavit

Relationship likelihood: Strong

Member, Supervisory Board at ProQR Therapeutics NV

Relationship likelihood: Strong

Former Chief Medical Officer at GlaxoSmithKline Plc

Relationship likelihood: Strong

Chief Executive Officer at Kaleido Biosciences, Inc.

Relationship likelihood: Strong

Chief Executive Officer at ProQR Therapeutics NV

Relationship likelihood: Strong

Chief Financial Officer at ProQR Therapeutics NV

Relationship likelihood: Strong

Member of the Management Board, Chief Corporate Development Officer & General Counsel at ProQR Therapeutics NV

Relationship likelihood: Strong

Diplomat at American Board of Toxicology

Relationship likelihood: Strong

Head of Medical Genitourinary Oncology at Albert Einstein College of Medicine, Inc.

Relationship likelihood: Strong

Paths to Gerard J. Platenburg
Potential Connections via
Relationship Science
You
Gerard J. Platenburg
Co-Founder at ProQR Therapeutics NV
Education
Graduate
Class of 1987

Leiden University (Dutch: Universiteit Leiden), located in the city of Leiden, is the oldest university in the Netherlands.[4] The university was founded in 1575 by William, Prince of Orange, leader of the Dutch Revolt in the Eighty Years' War. The Dutch Royal Family and Leiden University still have a close relationship; Queens Juliana and Beatrix and King Willem-Alexander are all former students. Leiden University has six faculties, over 50 departments and enjoys an outstanding international reputation. In 2013 Leiden was the highest ranked university in the Netherlands in the Times Higher Education World University Rankings, where it was rated as the 64th best university worldwide and 61st for international reputation. Shanghai Jiao Tong University's 2011 Academic Ranking of World Universities ranked Leiden University as the 65th best university worldwide.[5] The Times Higher Education World University Rankings consistently rank Leiden University as the best university in Continental Europe for Arts and Humanities. The University is associated with ten leaders and Prime Ministers of the Netherlands including the current Prime Minister Mark Rutte, nine foreign leaders, among them the 6th President of the United States John Quincy Adams, two Secretary Generals of NATO, a President of the International Court of Justice and sixteen recipients of the Nobel Prize (including renowned physicists Albert Einstein and Enrico Fermi). The university came into particular prominence during the Dutch Golden Age, when scholars from around Europe were attracted to the Dutch Republic due to its climate of intellectual tolerance and Leiden's international reputation. During this time Leiden was home to such figures as René Descartes, Rembrandt, Hugo Grotius, Baruch Spinoza and Baron d'Holbach. The university is a member of the Coimbra Group, the Europaeum and the League of European Research Universities. Albert Einstein was known as a professor at Leiden University. Einstein regularly taught Leiden students for a few weeks per year. His first lecture at Leiden was about "Ether and Relativity Theory".[6] Leiden University houses more than 40 national and international research institutes.

Career History
Co-Founder
2012 - Current

ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Chief Operating Officer
? - 2014

ISA Pharmaceuticals BV develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded in 2004 and is headquartered in Leiden, the Netherlands.

Chief Executive Officer
2002 - Prior

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

Boards & Committees
Member, Scientific Advisory Board
2017 - Current

Amylon Therapeutics is a biotechnology company that targets CNS disorders through an ultra-genetics approach.

Chair, Scientific Advisory Board
Current

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Member Advisory Board
Prior

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

Investments
Details Hidden

ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Details Hidden

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

Details Hidden
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gerard J. Platenburg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gerard J. Platenburg's profile does not indicate a business or promotional relationship of any kind between RelSci and Gerard J. Platenburg.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/gerard-j-platenburg-3740942
  • https://relationshipscience.com/person/gerard-j-platenburg-3740942